Answers are grounded in this paper and cite their sources.
Functional and structural connectomes (FC/SC) are informative biomarkers for brain disorders, yet their clinical use remains limited by acquisition cost, lengthy connectome construction pipelines, and missing modalities in real-world neuroimaging studies. To address these challenges, we introduce BrainCSD (Brain Connectivity Synthesis and Decode), a hierarchical Mixture-of-Experts (MoE) framework for connectome-oriented representation learning and missing-modality connectome synthesis. BrainCSD does not require precomputed FC/SC matrices as direct inputs, but learns neuroanatomically constrained representations from fMRI or dMRI inputs with template- and atlas-based anatomical correspondence. Its architecture incorporates three consistency constraints: ROI-level alignment, encoding-level consistency, and network-level refinement. We evaluate BrainCSD across 7248 participants, 22 imaging sites, 9 datasets, 5 neurological and neurodevelopmental disorders, and 15 downstream tasks, including connectome synthesis, disease classification, brain-age prediction, and MMSE estimation. BrainCSD-generated connectomes provide useful complementary information for downstream diagnostic and trait prediction tasks. Additional balanced metrics, graph-topological analyses, and subgroup evaluations further support the potential utility of BrainCSD for connectome-based analysis. Nevertheless, the current results are based primarily on within-dataset validation, and larger prospective external validation, uncertainty calibration, and clinical expert assessment are required before any clinical use.
No takes yet. Share an insight, caveat, or question.
Shen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: